|
Placebo
|
Whey
|
Soy
|
---|
Pre
|
Post-Load
|
24 h
|
Pre
|
Post-Load
|
24 h
|
Pre
|
Post-Load
|
24 h
|
---|
CON-KE-DL (Nm)
|
258.4 ± 25.1
|
256.2 ± 25.8
|
220.8 ± 26.2a
|
259.0 ± 33.4
|
256.3 ± 26.8
|
230.7 ± 32.4b
|
255.8 ± 30.0
|
258.3 ± 23.0
|
227.3 ± 33.9c
|
CON-KE-NDL (Nm)
|
257.8 ± 33.5
|
255.1 ± 33.1
|
221.6 ± 31.5a
|
256.9 ± 28.7
|
258.7 ± 26.2
|
227.3 ± 31.1b
|
257.8 ± 31.2
|
256.2 ± 24.7
|
229.4 ± 22.7c
|
CON-KF-DL (Nm)
|
157.0 ± 22.8
|
156.4 ± 22.6
|
142.1 ± 22.0a
|
158.2 ± 21.7
|
156.9 ± 23.5
|
144.0 ± 21.1b
|
156.2 ± 23.9
|
155.4 ± 22.6
|
141.8 ± 22.4c
|
CON-KF-NDL (Nm)
|
155.1 ± 23.2
|
155.9 ± 22.9
|
140.6 ± 26.2a
|
156.7 ± 22.4
|
155.5 ± 23.8
|
142.4 ± 21.5b
|
154.9 ± 22.8
|
154.0 ± 23.5
|
141.6 ± 22.1c
|
ECC-KE-DL (Nm)
|
330.5 ± 73.5
|
333.9 ± 74.1
|
281.7 ± 81.6a
|
332.6 ± 72.7
|
331.4 ± 72.9
|
289.9 ± 80.6b
|
330.6 ± 72.6
|
332.8 ± 74
|
291.8 ± 65.4c
|
ECC-KE-NDL (Nm)
|
329.2 ± 47.8
|
328.3 ± 48.0
|
284.9 ± 44.4a
|
329.7 ± 53.8
|
328.6 ± 51.4
|
288.4 ± 54.5b
|
328.9 ± 52.0
|
329.9 ± 48.8
|
289.2 ± 49.5c
|
ECC-KF-DL (Nm)
|
193.3 ± 31.3
|
192.0 ± 32.0
|
154.1 ± 31.1a
|
195.8 ± 24.4
|
197.4 ± 25.7
|
167.0 ± 28.9b
|
196.5 ± 25.1
|
194.7 ± 20.0
|
164.8 ± 23.8c
|
ECC-KF-NDL (Nm)
|
192.7 ± 18.7
|
193.5 ± 23.4
|
156.4 ± 27.8a
|
194.2 ± 21.1
|
193.4 ± 26.2
|
168.2 ± 20.1b
|
195.4 ± 22.1
|
194.0 ± 19.6
|
166.5 ± 26.3c
|
10 m sprint time (sec)
|
1.908 ± 0.076
|
1.938 ± 0.099
|
2.020 ± 0.125a
|
1.934 ± 0.068
|
1.942 ± 0.069
|
1.984 ± 0.090
|
1.896 ± 0.076
|
1.931 ± 0.081
|
1.951 ± 0.136
|
30 m sprint time (sec)
|
4.580 ± 0.140
|
4.565 ± 0.161
|
4.818 ± 0.147a
|
4.587 ± 0.172
|
4.574 ± 0.179
|
4.735 ± 0.178b
|
4.567 ± 0.150
|
4.591 ± 0.130
|
4.743 ± 0.145c
|
RSA fatigue index (%)
|
6.39 ± 1.23
|
6.43 ± 1.16
|
7.65 ± 1.57a
|
6.45 ± 1.07
|
6.43 ± 1.02
|
7.32 ± 1.27b
|
6.41 ± 0.96
|
6.44 ± 0.73
|
7.43 ± 0.80c
|
CMJ (cm)
|
47.1 ± 3.4
|
47.6 ± 4.3
|
43.8 ± 3.6a
|
47.3 ± 3.1
|
47.0 ± 3.0
|
44.9 ± 2.5b
|
46.9 ± 3.2
|
46.5 ± 3.0
|
44.3 ± 2.5c
|
- CON concentric, ECC eccentric, KE knee extensors, KF knee flexors, DL dominant limb, NDL non-dominant limb, RSA repeated sprint ability, CMJ countermovement jump. Note: Data are presented as means ± SD. a denotes a significant difference with pre in placebo at P < 0.05. b denotes a significant difference with pre in whey at P < 0.05. c denotes a significant difference with pre in soy at P < 0.05